Financial toxicity of patients with lung cancer in China: Results from a National Survey Study.
Meicen LiuDengmin HuangYuanli LiuPublished in: Cancer medicine (2022)
Despite China's remarkable progress in the past two decades with regard to Universal Healthcare Coverage, FT still presents a serious challenge for patients with lung cancer. Keen attention must be paid to reducing the disproportionate high financial risks of patients with low socioeconomic status.